Table 2.
Effect of treatment on the values of clinical measures in AIH patients.
| Parameters | Before treatment | After treatment |
|---|---|---|
| Number | 17 | 17 |
| Age (years) | 43 (38–76) | 43 (38–76) |
| Gender: female/male | 14/3 | 14/3 |
| ALT (U/L) | 192.3 ± 108.7∗ | 36.8 ± 10.9 |
| AST (U/L) | 131.8 ± 55.7∗ | 44.2 ± 11.88 |
| GGT (U/L) | 107.1 ± 27.1∗ | 76.1 ± 24.9 |
| ALP (U/L) | 153.2 ± 32.7∗ | 95.4 ± 23.7 |
| IgG (g/L) | 18.2 ± 2.9∗ | 8.8 ± 3.4 |
| IgM (g/L) | 7.7 ± 1.6∗ | 4.52 ± 2.3 |
| IgA (g/L) | 3.8 ± 1.5∗ | 2.6 ± 1.0 |
Data shown are real case number or mean ± SD. Normal values: ALT: <40 IU/L; AST: <40 IU/L. IgG: normal range = 7–16 g/L; IgM: normal range = 0.7–4.6 g/L; IgA: normal range = 0.4–2.3 g/L. HC: healthy control; AIH: autoimmune hepatitis. ∗P < 0.05 versus posttreatment.